Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2025-12-25 @ 3:27 AM
NCT ID: NCT00209105
Eligibility Criteria: Inclusion Criteria: * For participants assigned to the MDD groups: current DSM-IV diagnosis of MDD * For participants assigned to the early-life stress group: repeated (once per month or more for at least year) sexual or physical abuse before the age of 13 years by a perpetrator at least 5 years older at the time * For female participants: regular menstrual cycle and assessment in the early follicular phase as verified by sex steroid measures Exclusion Criteria: * Meets DSM-IV criteria for a gender identity disorder * For all participants assigned to non-MDD groups: DSM-IV diagnosis of current MDD * For all participants assigned to the group without early-life stress: major stress experiences before the age of 12 years, such as separation from parents, neglect, parental loss, accidents, severe illness, or natural disaster * Significant medical illness, such as gastrointestinal, neurological, hormonal, heart, lung, kidney, liver, immunological or hematological disease, organic brain disease, or cancer as determined by history, physical examination, ECG, and laboratory tests * Pregnant or breastfeeding * Past or current presence of psychotic symptoms or bipolar disorder * Current presence of psychoactive substance abuse/dependency or eating disorders * Currently taking hormonal medication * Taking psychotropic medication within 4 weeks of study entry * General exclusion criteria for PET and fMRI
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 45 Years
Study: NCT00209105
Study Brief:
Protocol Section: NCT00209105